PET and the investigation of dementia in the parkinsonian patient

Journal of Neural Transmission, Supplement

Volumn , Issue 51, 1997, Pages 37-48

  Turjanski, N ^a   Brooks, D J ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CARBIDOPA PLUS LEVODOPA; DIAZEPAM; FLUORODEOXYGLUCOSE F 18; FLUOXETINE; SELEGILINE;

AGED; ALZHEIMER DISEASE; APRAXIA; BASAL GANGLION; BRAIN CORTEX; BRAIN DEGENERATION; BRAIN METABOLISM; BRAIN STEM; CASE REPORT; COGNITIVE DEFECT; CONFERENCE PAPER; DEMENTIA; DIFFUSE LEWY BODY DISEASE; DISEASE ASSOCIATION; FEMALE; HUMAN; HYPOTHALAMUS; INTRAVENOUS DRUG ADMINISTRATION; MALE; PARKINSONISM; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; BRAIN CIRCULATION; COMPUTER ASSISTED EMISSION TOMOGRAPHY; PARKINSON DISEASE; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; SCINTISCANNING;

AGED; CEREBROVASCULAR CIRCULATION; DEMENTIA; FEMALE; HUMANS; MALE; PARKINSON DISEASE; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0031283217     PISSN: 03036995     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-7091-6846-2_4     Document Type: Conference Paper

References (68)

1. Alavi A, Dann R, Chawluk J, Alavi J, Kushner M, Reivich M (1986) Positron emission tomography imaging of regional cerebral glucose metabolism. Semin Nucl Med 16: 2-34
2. Blin J, Baron JC, Dubois B, Pillon B, Cambon H, Cambier J, Agid Y (1990a) Positron emission tomography study in progressive supranuclear palsy. Brain hypometabolic pattern and clinicometabolic correlations. Arch Neurol 47: 747-752
3. Blin J, Vidailhet M, Bonnet AM, Dubois B, Pillon B, Syrota A, Agid Y (1990b) PET study in cortico-basal degeneration. Mov Disord 5 [Suppl 1]: 19
4. Blin J, Vidailhet M-J, Pillon B, Dubois B, Feve J-R, Agid Y (1992) Corticobasal degeneration: decreased and asymmetrical glucose consumption as studied with PET. Mov Disord 7: 348-354
5. Brooks DJ (1994) PET studies in progressive supranuclear palsy. J Neural Transm [Suppl 42]: 119-134
6. Brown RG, Marsden CD (1984) How common is dementia in Parkinson's disease? Lancet ii: 1262-1265
7. 18F-dopa PET data. J Neurol Neurosurg Psychiatry 57: 278-284
8. Byrne J, Lennox G, Lowe J, Godwin-Austen RB (1989) Diffuse Lewy body disease: clinical features in 15 cases. J Neurol Neurosurg Psychiatry 52: 709-717
9. Chase TN, Foster NL, Fedio P, Brooks R, Mansi L, Di Chiro G (1984) Regional cortical dysfunction in Alzheimer's disease as determined by positron emission tomography. Ann Neurol 15 [Suppl]: S170-S174
10. Colosimo C, Albanese A, Hughes AJ, De Bruin VMS, Lees AJ (1995) Some specific clinical features differentiate multiple system atrophy (striatonigral variety) from Parkinson's disease. Arch Neurol 52: 294-298
11. 99m]Tc-HM-PAO in patients with dementia (Alzheimer's type and HIV) and Parkinson's disease-initial results. J Cereb Blood Flow Metab 8 [Suppl 1]: S109-S115
12. Crystal HA, Dickson DW, Lizardi JE, Davies P, Wolfson LI (1990) Antemortem diagnosis of diffuse Lewy body disease. Neurology 40: 1523-1528
13. De Bruin VMS, Lees AJ (1994) Subcortical neurofibrillary degeneration presenting as Steele-Richardson-Olszewski and other related syndromes: a review of 90 pathologically verified cases. Mov Disord 9: 381-389
14. Ditter SM, Mirra SS (1987) Neuropathologic and clinical features of Parkinson's disease in Alzheimer's disease patients. Neurology 37: 754-760
15. Duvoisin RC (1994) Differential diagnosis of PSP. J Neural Transm [Suppl 42]: 51-67
16. 18F]Fluorodopa positron emission tomographic studies. Mov Disord 5: 203-213
17. Eidelberg D, Dhawan V, Moeller JR, Sidtis JJ, Ginos JZ, Strother SC, Cederbaum J, Greene P, Fahn S, Powers JM, Rottenberg DA (1991) The metabolic landscape of cortico-basal ganglionic degeneration: regional asymmetries studied with positron emission tomography. J Neurol Neurosurg Psychiatry 54: 856-862
18. Eidelberg D, Moeller JR, Dhawan V, Spetsieris P, Takikawa S, Ishikawa T, Chaly T, Robeson W, Margouleff D, Przedborski S, Fahn S (1994) The metabolic topography of parkinsonism. J Cereb Blood Flow Metab 14: 783-801
19. Fearnley JM, Revesz T, Brooks DJ, Frackowiack RSJ, Lees AJ (1991) Diffuse Lewy body disease presenting with a supranuclear gaze palsy. J Neurol Neurosurg Psychiatry 54: 159-161
20. Foster NL, Chase TN, Fedio P, Patronas NJ, Brooks RA, Di Chiro G (1983) Alzheimer's disease: focal cortical changes shown by positron emission tomography. Neurology 33: 961-965
21. Foster NL, Gilman S, Berent S, Sima AAF, D'Amato C, Koeppe RA, Hicks SP (1992) Progressive subcortical gliosis and progressive supranuclear palsy can have similar clinical and PET abnormalities. J Neurol Neurosurg Psychiatry 55: 707-713
22. Frackowiak RSJ, Friston KJ (1994) Functional neuroanatomy of the human brain: positron emission tomography -a new neuroanatomical technique. J Anat 184: 211-225
23. Frackowiak RSJ, Pozilli C, Legg, NJ, Du Boulay GH, Marshall J, Lenzi GL, Jones T (1981) Regional cerebral oxygen supply and utilization in dementia. Brain 104: 753-778
24. 18F]Fluorodeoxyglucose. J Comput Assist Tomogr 7: 590-598
25. Friston KJ (1995) Statistical parametric mapping: ontology and current issues. J Cereb Blood Flow Metab 15: 361-370
26. Gibb WRG, Luthert PJ (1994) Dementia in Parkinson's disease and Lewy body disease. In: Burns A, Levy R (eds) Dementia. Chapman & Hall, London, pp 719-738
27. Gibb WRG, Esiri MM, Lees AJ (1985) Clinical and pathological features of diffuse cortical Lewy body disease (Lewy body dementia). Brain 110: 1131-1153
28. Goffinet AM, De Volder AG, Gillain C, Rectem D, Bol A, Michel C, Cogneau M, Labar D, Laterre C (1989) Positron tomography demonstrates frontal lobe hypometabolism in progressive supranuclear palsy. Ann Neurol 25: 131-139
29. Golbe LI, Miller DC, Duvoisin RC (1989) Paraneoplastic degeneration of the substantia nigra with dystonia and parkinsonism. Mov Disord 4: 147-152
30. Goto I, Taniwaki T, Hosokawa S, Otsuka M, Ichiya Y, Ichimiya A (1993) Positron emission tomographic (PET) studies in dementia. J Neurol Sci 114: 1-6
31. Hansen L, Salmon D, Galasko D, Mesliah E, Katzman R, DeTeresa R, Thai L, Pay MM, Hofstetter R, Klauber M, Rice V, Butters N, Alford M (1990) The Lewy body variant of Alzheimer's disease: a clinical and pathologic entity. Neurology 40: 1-8
32. Hansen LA, Galasko D (1995) Lewy body disease. Curr Opin Neurol Neurosurg 5: 889-894
33. Hughes AJ, Daniel SE, Blankson S, Lees AJ (1993) A clinicopathologic study of 100 cases of Parkinson's disease. Arch Neurol 50: 140-148
34. Jellinger K, Grisold W (1982) Cerebral atrophy in Parkinson syndrome. Exp Brain Res [Suppl] 5: 26-35
35. Johnson KA, Sperling RA, Holman BL, Nagel JS, Growdon JH (1992) Cerebral perfusion in progressive supranuclear palsy. J Nucl Med 33: 704-709
36. Karbe H, Holthoff V, Huber M, Herholz Z, Wienhard K, Wagner R, Heiss WD (1992) Positron emission tomography in degenerative disorders of the dopaminergic system. J Neural Transm [PD Sect] 4: 121-130
37. Kennedy AM, Frackowiak RSJ, Newman SK, Bloomfield PM, Seaward J, Roques P, Lewington G, Cunningham VJ, Rossor MN (1995) Deficits in cerebral glucose metabolism demonstrated by positron emission tomography in individuals at risk of familial Alzheimer's disease. Neurosci Lett 186: 17-20
38. Kosaka K (1978) Lewy bodies in cerebral cortex. Report of three cases. Acta Neuropathol 42: 127-134
39. Kosaka K (1990) Diffuse Lewy body disease in Japan. J Neurol 237: 197-204
40. Kosaka K, Yoshimura M, Ikeda K, Budka H (1984) Diffuse type of Lewy body disease: progressive dementia with abundant cortical Lewy bodies and senile changes of various degree -a new disease? Clin Neuropathol 3: 185-192
41. 18F]Fluorodeoxyglucose method. Ann Neurol 15: 419-424
42. Kuhl DE, Metter EJ, Riege WH, Markham CH (1984b) Patterns of cerebral glucose utilization in Parkinson's disease and Huntington's disease. Ann Neurol 15 [Suppl]: S119-S125
43. Lees AJ (1985) Parkinson's disease and dementia. Lancet i: 43-44
44. Litvan I (1994) Cognitive disturbances in progressive supranuclear palsy. J Neural Transm [Suppl 42]: 69-78
45. Mayeux R, Stern Y, Spanton S (1985) Heterogeneity in dementia of the Alzheimer's type: evidence of subgroups. Neurology 35: 453-461
46. McKeith I, Fairbairn A, Perry R, Thompson P, Perry E (1992) Neuroleptic sensitivity in patients with senile dementia of Lewy body type. BMJ 305: 673-678
47. Mc Keith IG, Galesko D, Kosaka K, Perry EK, Dickson DW, Hansen LA, Salmon DP, Lowe J, Mirra SS, Byrne EJ, Lennox G, Quinn NP, Edwardson JA, Ince PG, Bergeron C, Burns A, Miller BL, Lovestone S, Collerton D, Jansen ENH, Ballard C, de Vos RAI, Wilcock GK, Jellinger KA, Perry RH for the Consortium on Dementia with Lewy Bodies (1996) Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 47: 1113-1124
48. Miletich RS, Chase T, Gillespie M, Di Chiro G, Stein S (1988) Contralateral basal ganglia glucose metabolism is abnormal in hemi-parkinsonian patients: an FDG-PET study. Neurology 38 [Suppl 1]: 260
49. Molsa PK, Marttila RJ, Rinne UK (1984) Extrapyramidal signs in Parkinson's disease. Neurology 34: 1114-1116
50. Murray AM, Weihmueller FB, Marshall JF, Hurtig HI, Gottleib GL, Joyce JN (1995) Damage to dopamine systems differs between Parkinson's disease and Alzheimer's disease with parkinsonism. Ann Neurol 37: 300-312
51. Okada J, Peppard R, Calne DB (1989) Comparison study of positron emission tomography, X-ray CT and MRI in parkinsonism with dementia. Nippon Igaku Hoshasen Gakkai Zasshi 49: 643-656
52. 18F-dopa uptake: difference in Parkinson's disease and atypical parkinsonism. J Neurol Neurosurg Psychiatry 54: 898-904
53. Peppard RF, Martin WRW, Guttman M, McGeer PL, Walsh EM, Carr GD, Phillips AG, Grochowski E, Okada J, Tsui JKC, Mak E, Ruth E, Adam MJ, Calne DB (1988) The relationship of cerebral glucose metabolism to cognitive deficits in Parkinson's disease. Neurology 38 [Suppl 1]: 364
54. Peppard RF, Martin WR, Clark CM, Carr GD, McGeer PL, Calne DB (1990) Cortical glucose metabolism in Parkinson's and Alzheimer's disease. J Neurosci Res 27: 561-568
55. Perlmutter JS, Raichle ME (1985) Regional blood flow in hemiparkinsonism. Neurology 35: 1127-1134
56. Perry EK, McKeith I, Thompson P, Marshall E, Kerwin J, Jabeen S, Edwardson JA, Ince P, Blessed G, Irving D, Perry RH (1991) Topography, extent, and clinical relevance of neurochemical deficits in dementia of Lewy body type, Parkinson's disease, and Alzheimer's disease. Ann NY Acad Sci 640: 197-202
57. Perry RH, Irving D, Blessed G, Perry EK, Fairbairn AF (1989) Senile dementia of Lewy body type and spectrum of Lewy body disease. Lancet i: 1088
58. Rebeiz JJ, Kolodny EH, Richardson EP (1968) Corticodentatonigral degeneration with neuronal achromasia. Arch Neurol 18: 20-33
59. Rinne JO, Lee MS, Thompson PD, Marsden CD (1994) Corticobasal degeneration. A clinical study of 36 cases. Brain 117: 1183-1196
60. Sawada H, Udaka F, Kameyama M, Seriu N, Nishinaka K, Shindou K, Kodama M, Nishitani N, Okumiya K (1992) SPECT findings in Parkinson's disease associated with dementia. J Neurol Neurosurg Psychiatry 55: 960-963
61. Sawle GV, Brooks DJ, Marsden CD, Frackowiak RSJ (1991) Corticobasal degeneration. A unique pattern of regional cortical oxygen hypometabolism and striatal fluorodopa uptake demonstrated by positron emission tomography. Brain 114: 541-556
62. Schapiro MB, Grady C, Ball MJ, DeCarli C, Rapoport SI (1990) Reductions in parietal/ temporal cerebral glucose metabolism are not specific for Alzheimer's disease. Neurology 40 [Suppl 1]: 152
63. Schmidt ML, Murray J, Lee VM-Y, Hill WD, Wertkin A, Trojanowski JQ (1991) Epitope map of neurofilament protein domains in cortical and peripheral nervous system Lewy bodies. Am J Pathol 139: 53-65
64. Smith FW, Besson JAO, Gemmell HG, Sharp PF (1988) The use of Technetium-99m-HM-PAO in the assessment of patients with dementia and other neuropsychiatric conditions. J Cereb Blood Flow Metab 8 [Suppl 1]: S116-S122
65. Tison F, Dartigues JF, Auriacombe S, Letenneur L, Boller F, Alperovitch A (1995) Dementia in Parkinson's disease: a population-based study in ambulatory and institutionalized individuals. Neurology 45: 705-708
66. Tolosa E, Valldeoriola F, Marti MJ (1994) Clinical diagnosis and diagnostic criteria of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome). J Neural Transm 42 [Suppl]: 15-31
67. Tyrrell PJ, Sawle GV, Ibanez V, Bloomfield PM, Leenders KL, Frackowiak RS, Rossor MN (1990) Clinical and positron emission tomographic studies in the "extrapyramidal syndrome" of dementia of the Alzheimer type. Arch Neurol 47: 1318-1323
68. Watts RL, Mirra SS, Richardson EP (1994) Corticobasal ganglionic degeneration. In: Marsden CD, Fahn S (eds) Movement disorders 3. Butterworth-Heinemann, London, pp 282-299